FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a compound of formula (I), in which radicals and groups have values given in the claim, or a pharmaceutically acceptable salt thereof and a pharmaceutical composition containing said compounds.
EFFECT: said compounds have activity to inhibit positive effect of factor Xa and can be used for preparing a drug for prevention and/or treatment of diseases, which inhibits positive action of factor Xa in case of low risk of bleeding.
18 cl, 6 tbl, 35 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BICYCLIC TETRAHYDROPYRAZOLEPYRIDINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION, METHOD OF PHOSPHODIESTERASE INHIBITION, METHOD OF PATIENT TREATMENT | 1994 |
|
RU2131876C1 |
| PRODRUGS OF CONJUGATED BICYCLIC C5aR ANTAGONISTS | 2019 |
|
RU2794327C2 |
| PYRAZOLOPYRIMIDONE OR PYRROLOTRIAZONE DERIVATIVES, METHOD OF PREPARING SAME AND PHARMACEUTICAL APPLICATIONS THEREOF | 2014 |
|
RU2674977C2 |
| SERINE/THREONINE KINASE INHIBITORS | 2013 |
|
RU2650501C2 |
| PYRIDONE AND AZA-PYRIDONE COMPOUNDS AND METHODS OF USE | 2011 |
|
RU2617405C2 |
| HALOGENALLILAMINE DERIVATIVES AND THEIR APPLICATIONS | 2020 |
|
RU2793850C2 |
| AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS | 2014 |
|
RU2741810C2 |
| SUBSTITUTED PYRAZOLES | 2001 |
|
RU2286343C2 |
| 5-HYDROXY-4-(TRIFLUOROMETHYL)PYRAZOLOPYRIDINE DERIVATIVE | 2014 |
|
RU2673810C1 |
| TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO-[3,4-C]-1,2,4-TRIAZOLO- -[4,3-A]-PYRIDINES, METHOD OF INHIBITION OF ACTIVITY OF PHOSPHODIESTERASE TYPE IV AND METHOD OF INHIBITION OF TUMOR-SPECIFIC NECROSIS FACTOR PRODUCING | 1996 |
|
RU2161158C2 |
